Agreement between DSM-III and III-R substance use disorders.
With proposed criteria for DSM-IV substance dependence imminent, an evaluation of the impact of changes from DSM-III to DSM-III-R would be informative. Recent admissions to St. Louis drug treatment centers were interviewed with the DIS-III-R, which covers criteria from both systems. Kappa values for system agreement, diagnostic overlap and percent positive agreement are reported by substance. The DSM-III-R system cast a wider net for dependence than DSM-III for alcohol, tobacco and amphetamines. Neither system predominated for cannabis, opioids and barbiturates/sedatives/hypnotics. Reasons for differences and implications of findings are discussed.
Cottler
L B
LB
Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110.
Helzer
J E
JE
Mager
D
D
Spitznagel
E L
EL
Compton
W M
WM
D000293:Adolescent; D000328:Adult; D000437:Alcoholism / Q000145:classification / Q000175:diagnosis / Q000523:psychology; D015897:Comorbidity; D004361:Drug Tolerance; D005260:Female; D015528:HIV Seroprevalence; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000145:classification / Q000175:diagnosis / Q000523:psychology; D011569:Psychiatric Status Rating Scales / Q000706:statistics & numerical data*; D011619:Psychotropic Drugs / Q000009:adverse effects; D012747:Sexual Partners / Q000523:psychology; D013375:Substance Withdrawal Syndrome / Q000145:classification / Q000175:diagnosis / Q000523:psychology; D019966:Substance-Related Disorders / Q000145:classification / Q000175:diagnosis* / Q000523:psychology
D011619:Psychotropic Drugs